- Home
- YDES vs LXEO Comparison
YDES vs LXEO Comparison
Compare YDES & LXEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Company Overview
Basic Information| Metric | YDES | LXEO |
|---|---|---|
| Founded | 2013 | 2017 |
| Country | Taiwan | United States |
| Employees | N/A | N/A |
| Industry | | |
| Sector | | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 894.2M | 731.3M |
| IPO Year | N/A | 2023 |
Fundamental Metrics
Financial Performance| Metric | YDES | LXEO |
|---|---|---|
| Price | $10.37 | $6.59 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 10 |
| Target Price | N/A | ★ $18.60 |
| AVG Volume (30 Days) | 39.8K | ★ 911.2K |
| Earning Date | 03-30-2026 | 03-23-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $510,360.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 45.76 | N/A |
| 52 Week Low | $5.30 | $1.45 |
| 52 Week High | $31.00 | $10.99 |
Technical Indicators
Market Signals| Indicator | YDES | LXEO |
|---|---|---|
| Relative Strength Index (RSI) | 36.59 | 33.85 |
| Support Level | $10.81 | $6.73 |
| Resistance Level | $11.80 | $7.31 |
| Average True Range (ATR) | 0.76 | 0.46 |
| MACD | -0.10 | -0.00 |
| Stochastic Oscillator | 13.69 | 17.16 |
Price Performance
Historical ComparisonAbout YDES YD Bio Limited Ordinary Shares
YD Bio Ltd is a biopharmaceutical company focusing on blood-based cancer detection, the development of stem cell- and exosome-based therapeutics with the potential to transform the treatment of a wide spectrum of diseases with high unmet medical need and serving as a trusted supplier of clinical testing drugs for pharmaceutical companies. Stem cell therapy uses versatile cells to repair or regenerate damaged tissues, offering innovative treatments for injuries, degenerative diseases, and immune disorders with potential for personalized medicine and tissue engineering.
About LXEO Lexeo Therapeutics Inc.
Lexeo Therapeutics Inc is a clinical-stage genetic medicines company committed to transforming healthcare by applying pioneering science to fundamentally alter how diseases are treated. The company focuses on preclinical and clinical stage gene therapies, specifically hereditary and acquired diseases with high unmet needs, which represent its sole business segment.